| Followers | 35 |
| Posts | 1912 |
| Boards Moderated | 0 |
| Alias Born | 11/05/2020 |
Saturday, January 31, 2026 9:12:28 PM
I didn't make anything up. All of that is verifiable.
R711 said they thought it was odd that the doctor running the trial in India used the phrase "it is useful." I would concur. Especially since this has been repeatably said it is a "revolutionary" and "groundbreaking" device.
You think you would write something a little more than that considering it was the first time it was implanted into a human being.
However, I know on the flip side according to the emails date of July 2025 it was only 8 months after that initial patient's implant.
Could be that 8 months wasn't a long time to probably call this anything more than "useful." Or he saw the real results of that patient and realized it was truly nothing more than "useful." A more polite way of speaking about the medical device rather than saying "junk."
Like I said, it's odd that they claimed it worked up to 80%. Where's the other 20%? What is the remission rate of the patient? There has been no update.
Either way, India has paused it. And the FDA saw all the data from that trial to still reject it.
R711 said they thought it was odd that the doctor running the trial in India used the phrase "it is useful." I would concur. Especially since this has been repeatably said it is a "revolutionary" and "groundbreaking" device.
You think you would write something a little more than that considering it was the first time it was implanted into a human being.
However, I know on the flip side according to the emails date of July 2025 it was only 8 months after that initial patient's implant.
Could be that 8 months wasn't a long time to probably call this anything more than "useful." Or he saw the real results of that patient and realized it was truly nothing more than "useful." A more polite way of speaking about the medical device rather than saying "junk."
Like I said, it's odd that they claimed it worked up to 80%. Where's the other 20%? What is the remission rate of the patient? There has been no update.
Either way, India has paused it. And the FDA saw all the data from that trial to still reject it.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
